Scilex (SCLX) said Thursday that it has closed an exchange of $200 million worth of common stock of its majority owned subsidiary Semnur Pharmaceuticals for $200 million in Bitcoin.
The company said the transaction with an institutional investor included 12.5 million Semnur shares at $16 per share.
Shares of Scilex were up 1% in recent premarket activity Thursday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.